🇬🇧 CAMBRIDGE PhD STUDENTSHIP 2026 IN CANCER BIOLOGY — UK (FULLY FUNDED)

Cambridge PhD Studentship 2026 offers a fully-funded PhD to investigate mechanisms of resistance to KRAS inhibition across pancreatic cancer genetic profiles. The project combines in vivo models, organoids, CRISPR, single-cell RNA sequencing, spatial transcriptomics, and other molecular techniques to define cell-intrinsic and cell-extrinsic resistance mechanisms.

SUMMARY
👉 Country: UK
👉 Host: University of Cambridge (Cancer Research UK Cambridge Institute)
👉 Study Level: PhD
👉 Benefit: Fully Funded
👉 Deadline: October 16, 2026

BENEFITS
👉 Fully-funded PhD studentship (stated as fully-funded in the listing)
👉 Project combines in vivo models, organoids, in vivo CRISPR, single-cell RNA sequencing, flow cytometry, multiplex immunofluorescence, spatial transcriptomics, and molecular biology approaches
👉 Computational component may be available depending on student skills and interests
👉 Further particulars available as a downloadable PDF

ELIGIBILITY
👉 Welcomes applications from both UK and overseas students
👉 Willingness to work with mouse models throughout the PhD is essential
👉 Prior experience in a laboratory or industry research environment is required
👉 Experience with tissue culture, including cell lines and/or organoids, is viewed favourably
👉 Experience with common laboratory techniques such as immunohistochemistry, western blotting, and/or PCR is advantageous
👉 Prior experience or knowledge of pancreatic cancer or cancer biology would be advantageous

HOW TO APPLY
https://scholarshipunion.com/cambridge-phd-studentship-2026-uk/